Cure My Disease

Don't miss your cure!

 Log in / Sign up

New wearable device listens for COPD Flare-Ups from home

NCT ID NCT06544928

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Strados Labs, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a wearable device called the RESP™ Biosensor that listens to lung sounds and chest movements. It is designed to help monitor people with COPD after they leave the hospital. The goal is to see if the device can detect early signs of a COPD flare-up, so patients can get help sooner. The study will follow 20 adults aged 40 to 80 who have recently been hospitalized for a COPD exacerbation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
RESP™ Biosensor (wearable device)
What this could lead to
If successful, this could lead to a reliable way to monitor COPD patients at home and catch worsening symptoms early, potentially reducing hospital visits.
What could go wrong
This is a very small, early feasibility study with only 20 participants. It is observational, so it won't prove the device improves health outcomes. The device may not detect exacerbations accurately in real-world conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease COPD, severe early onset

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COPD COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) WITH ACUTE LOWER RESPIRATORY INFECTION COPD EXACERBATION COPD EXACERBATION ACUTE

Contacts and locations

Locations

  • Jefferson Einstein Philadelphia Hospital

    Philadelphia, Pennsylvania, 19141, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.